Cortoss enters kyphoplasty trial in US:
This article was originally published in Clinica
Orthovita is to begin a second pilot clinical study to evaluate its Cortoss synthetic cortical bone void filler in the treatment of vertebral compression fractures (VCF) using a treatment technique called kyphoplasty. During kyphoplasty, an inflatable bone tamp is used to reduce the fracture and create a void in which the CORTOSS biomaterial can be injected. In January 2003, Orthovita began its first US pilot clinical study of CORTOSS for treating VCF using the vertebroplasty technique, whereby the biomaterial is injected without using the inflatable device. In the same month, the Malvern, Pennsylvania firm gained European approval to market the product for vertebral augmentation, including the repair of VCF.